Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Efficacy of azithromycin in severe asthma from the AMAZES randomised trial.

Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Marks GB, Baraket M, Powell H, Simpson JL.

ERJ Open Res. 2019 Dec 23;5(4). pii: 00056-2019. doi: 10.1183/23120541.00056-2019. eCollection 2019 Oct.

2.

Validation of the eighth edition TNM lung cancer staging system; a brief report.

Hwang JK, Page BJ, Flynn D, Passmore L, McCaul E, Brady J, Yang IA, Marshall H, Windsor M, Bowman RV, Naidoo R, Guan T, Philpot S, Blake ME, Fong KM.

J Thorac Oncol. 2019 Dec 18. pii: S1556-0864(19)33846-8. doi: 10.1016/j.jtho.2019.11.030. [Epub ahead of print]

PMID:
31863848
3.

'Omics': The new language in medicine that we all must learn.

Moodley Y, Yang IA.

Respirology. 2020 Feb;25(2):137-138. doi: 10.1111/resp.13754. Epub 2019 Dec 16. No abstract available.

4.

Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD.

Turner SW, Chang AB, Yang IA.

Breathe (Sheff). 2019 Dec;15(4):306-316. doi: 10.1183/20734735.0268-2019. Review.

5.

Potential clinical utility of multiple target quantitative polymerase chain reaction (qPCR) array to detect microbial pathogens in patients with chronic obstructive pulmonary disease (COPD).

O'Farrell HE, Shaw JG, Goh F, Bowman RV, Fong KM, Krause L, Yang IA.

J Thorac Dis. 2019 Oct;11(Suppl 17):S2254-S2265. doi: 10.21037/jtd.2019.10.39.

6.

Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation.

Pumar MI, Roll M, Fung P, Rolls TA, Walsh JR, Bowman RV, Fong KM, Yang IA.

J Thorac Dis. 2019 Oct;11(Suppl 17):S2238-S2253. doi: 10.21037/jtd.2019.10.23.

7.

Nutritional support in chronic obstructive pulmonary disease (COPD): an evidence update.

Collins PF, Yang IA, Chang YC, Vaughan A.

J Thorac Dis. 2019 Oct;11(Suppl 17):S2230-S2237. doi: 10.21037/jtd.2019.10.41. Review.

8.

Pre-hospital and emergency department pathways of care for exacerbations of chronic obstructive pulmonary disease (COPD).

Sneath E, Bunting D, Hazell W, Tippett V, Yang IA.

J Thorac Dis. 2019 Oct;11(Suppl 17):S2221-S2229. doi: 10.21037/jtd.2019.10.37. Review.

9.

Airway pharmacology: treatment options and algorithms to treat patients with chronic obstructive pulmonary disease.

Kerstjens HAM, Upham JW, Yang IA.

J Thorac Dis. 2019 Oct;11(Suppl 17):S2200-S2209. doi: 10.21037/jtd.2019.10.57. Review.

10.

COPD and the gut-lung axis: the therapeutic potential of fibre.

Vaughan A, Frazer ZA, Hansbro PM, Yang IA.

J Thorac Dis. 2019 Oct;11(Suppl 17):S2173-S2180. doi: 10.21037/jtd.2019.10.40. Review.

11.

Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis.

Parris BA, O'Farrell HE, Fong KM, Yang IA.

J Thorac Dis. 2019 Oct;11(Suppl 17):S2155-S2172. doi: 10.21037/jtd.2019.10.54. Review.

12.

Extracellular vesicles in chronic obstructive pulmonary disease (COPD).

O'Farrell HE, Yang IA.

J Thorac Dis. 2019 Oct;11(Suppl 17):S2141-S2154. doi: 10.21037/jtd.2019.10.16. Review.

13.

Diagnostic approach to chronic dyspnoea in adults.

Ferry OR, Huang YC, Masel PJ, Hamilton M, Fong KM, Bowman RV, McKenzie SC, Yang IA.

J Thorac Dis. 2019 Oct;11(Suppl 17):S2117-S2128. doi: 10.21037/jtd.2019.10.53. Review.

14.

Personalised multidisciplinary management for patients with chronic obstructive pulmonary disease (COPD).

Marshall HM, Vaughan A, Yang IA.

J Thorac Dis. 2019 Oct;11(Suppl 17):S2115-S2116. doi: 10.21037/jtd.2019.10.52. No abstract available.

15.

Euler-Lagrange Prediction of Diesel-Exhaust Polydisperse Particle Transport and Deposition in Lung: Anatomy and Turbulence Effects.

Islam MS, Saha SC, Gemci T, Yang IA, Sauret E, Ristovski Z, Gu YT.

Sci Rep. 2019 Aug 27;9(1):12423. doi: 10.1038/s41598-019-48753-6.

16.

The cytotoxic, inflammatory and oxidative potential of coconut oil-substituted diesel emissions on bronchial epithelial cells at an air-liquid interface.

Vaughan A, Stevanovic S, Banks APW, Zare A, Rahman MM, Bowman RV, Fong KM, Ristovski ZD, Yang IA.

Environ Sci Pollut Res Int. 2019 Sep;26(27):27783-27791. doi: 10.1007/s11356-019-05959-5. Epub 2019 Jul 24.

PMID:
31342346
17.

Cost of screening for lung cancer in Australia.

Marshall HM, Finn N, Bowman RV, Passmore LH, McCaul EM, Yang IA, Connelly L, Fong KM.

Intern Med J. 2019 Nov;49(11):1392-1399. doi: 10.1111/imj.14439.

PMID:
31336016
18.

Provenance of uranium particulate contained within Fukushima Daiichi Nuclear Power Plant Unit 1 ejecta material.

Martin PG, Louvel M, Cipiccia S, Jones CP, Batey DJ, Hallam KR, Yang IAX, Satou Y, Rau C, Mosselmans JFW, Richards DA, Scott TB.

Nat Commun. 2019 Jun 26;10(1):2801. doi: 10.1038/s41467-019-10937-z.

19.

Whole-genome sequencing of human malignant mesothelioma tumours and cell lines.

Oey H, Daniels M, Relan V, Chee TM, Davidson MR, Yang IA, Ellis JJ, Fong KM, Krause L, Bowman RV.

Carcinogenesis. 2019 Jul 6;40(6):724-734. doi: 10.1093/carcin/bgz066.

PMID:
31038674
20.

CRISPR-Cas9 technology: A new direction for personalized medicine in respiratory disease?

Vaughan A, Yang IA.

Respirology. 2019 Jul;24(7):614-615. doi: 10.1111/resp.13570. Epub 2019 Apr 29. No abstract available.

PMID:
31033105
21.

Evaluation of an innovative mobile health programme for the self-management of chronic obstructive pulmonary disease (MH-COPD): protocol of a randomised controlled trial.

Ding H, Karunanithi M, Ireland D, McCarthy L, Hakim R, Phillips K, Pradhan R, Seah EH, Bowman RV, Fong K, Masel P, Yang IA.

BMJ Open. 2019 Apr 25;9(4):e025381. doi: 10.1136/bmjopen-2018-025381.

22.

Long-Term Azithromycin Reduces Haemophilus influenzae and Increases Antibiotic Resistance in Severe Asthma.

Taylor SL, Leong LEX, Mobegi FM, Choo JM, Wesselingh S, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Baraket M, Marks GB, Gibson PG, Rogers GB, Simpson JL.

Am J Respir Crit Care Med. 2019 Aug 1;200(3):309-317. doi: 10.1164/rccm.201809-1739OC.

PMID:
30875247
23.

Clinical management practices of life-threatening asthma: an audit of practices in intensive care.

Secombe P, Stewart P, Singh S, Campbell L, Stephens D, Tran K, White H, Sheehy R, Gibson J, Cooke R, Townsend S, Apte Y, Winearls J, Ferry OR, Pradhan R, Ziegenfuss M, Fong KM, Yang IA, McGinnity P, Meyer J, Walsham J, Boots R, Clement P, Bandeshe H, Gracie C, Jarret P, Collins S, Coulston C, Ng M, Howells V, Chatterjee I, Visser A, Smith J, Trout M; Critical Care Asthma Investigators .

Crit Care Resusc. 2019 Mar;21(1):53-62.

PMID:
30857513
24.

Primary human bronchial epithelial cell responses to diesel and biodiesel emissions at an air-liquid interface.

Vaughan A, Stevanovic S, Jafari M, Bowman RV, Fong KM, Ristovski ZD, Yang IA.

Toxicol In Vitro. 2019 Jun;57:67-75. doi: 10.1016/j.tiv.2019.02.005. Epub 2019 Feb 7.

PMID:
30738890
25.

A sputum 6-gene signature predicts future exacerbations of poorly controlled asthma.

Fricker M, Gibson PG, Powell H, Simpson JL, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Marks GB, Baraket M, Baines KJ.

J Allergy Clin Immunol. 2019 Jul;144(1):51-60.e11. doi: 10.1016/j.jaci.2018.12.1020. Epub 2019 Jan 22.

PMID:
30682452
26.

The effect of diesel emission exposure on primary human bronchial epithelial cells from a COPD cohort: N-acetylcysteine as a potential protective intervention.

Vaughan A, Stevanovic S, Jafari M, Rahman M, Bowman RV, Fong KM, Ristovski Z, Yang IA.

Environ Res. 2019 Mar;170:194-202. doi: 10.1016/j.envres.2018.12.035. Epub 2018 Dec 18.

PMID:
30590262
27.

Polydisperse Microparticle Transport and Deposition to the Terminal Bronchioles in a Heterogeneous Vasculature Tree.

Islam MS, Saha SC, Gemci T, Yang IA, Sauret E, Gu YT.

Sci Rep. 2018 Nov 6;8(1):16387. doi: 10.1038/s41598-018-34804-x.

28.

Subtype variation and actionability of telomere length abnormality in lung cancer.

Goh F, Yang IA, Bowman RV, Fong KM.

Transl Lung Cancer Res. 2018 Sep;7(Suppl 3):S251-S253. doi: 10.21037/tlcr.2018.09.03. No abstract available.

29.

Interstitial lung abnormalities in the Queensland Lung Cancer Screening Study: prevalence and progression over 2 years of surveillance.

Mackintosh JA, Marshall HM, Slaughter R, Reddy T, Yang IA, Bowman RV, Fong KM.

Intern Med J. 2019 Jul;49(7):843-849. doi: 10.1111/imj.14148.

PMID:
30350396
30.

The contribution of respiratory microbiome analysis to a treatable traits model of care.

Taylor SL, O'Farrell HE, Simpson JL, Yang IA, Rogers GB.

Respirology. 2019 Jan;24(1):19-28. doi: 10.1111/resp.13411. Epub 2018 Oct 3. Review.

31.

Treatable traits can be identified in a severe asthma registry and predict future exacerbations.

McDonald VM, Hiles SA, Godbout K, Harvey ES, Marks GB, Hew M, Peters M, Bardin PG, Reynolds PN, Upham JW, Baraket M, Bhikoo Z, Bowden J, Brockway B, Chung LP, Cochrane B, Foxley G, Garrett J, Jayaram L, Jenkins C, Katelaris C, Katsoulotos G, Koh MS, Kritikos V, Lambert M, Langton D, Lara Rivero A, Middleton PG, Nanguzgambo A, Radhakrishna N, Reddel H, Rimmer J, Southcott AM, Sutherland M, Thien F, Wark PAB, Yang IA, Yap E, Gibson PG.

Respirology. 2019 Jan;24(1):37-47. doi: 10.1111/resp.13389. Epub 2018 Sep 19.

32.

How do new molecular tools apply to my clinical practice?

Yang IA, Moodley Y.

Respirology. 2018 Nov;23(11):991-992. doi: 10.1111/resp.13381. Epub 2018 Aug 14. No abstract available.

33.

Diagnosis of the cause of chronic dyspnoea in primary and tertiary care: characterizing diagnostic confidence.

Huang YC, Ferry OR, McKenzie SC, Bowman RV, Hamilton M, Masel PJ, Fong KM, Yang IA.

J Thorac Dis. 2018 Jun;10(6):3745-3756. doi: 10.21037/jtd.2018.05.183.

34.

Prostate-specific membrane antigen avidity on positron emission tomography scan in malignant pleural mesothelioma.

Ekanayake SKDM, Yang IA, Godbolt DB, Windsor MN, Henderson D, Kyle S, Sterling D, Lee JC.

ANZ J Surg. 2019 Sep;89(9):E406-E407. doi: 10.1111/ans.14694. Epub 2018 Jun 5. No abstract available.

PMID:
29873168
35.

Working while unwell: Workplace impairment in people with severe asthma.

Hiles SA, Harvey ES, McDonald VM, Peters M, Bardin P, Reynolds PN, Upham JW, Baraket M, Bhikoo Z, Bowden J, Brockway B, Chung LP, Cochrane B, Foxley G, Garrett J, Hew M, Jayaram L, Jenkins C, Katelaris C, Katsoulotos G, Koh MS, Kritikos V, Lambert M, Langton D, Lara Rivero A, Marks GB, Middleton PG, Nanguzgambo A, Radhakrishna N, Reddel H, Rimmer J, Southcott AM, Sutherland M, Thien F, Wark PAB, Yang IA, Yap E, Gibson PG.

Clin Exp Allergy. 2018 Jun;48(6):650-662. doi: 10.1111/cea.13153. Epub 2018 May 17.

PMID:
29676834
36.

Editorial on PanCan study.

Marshall HM, Yang IA, Bowman RV, Fong KM.

Transl Lung Cancer Res. 2018 Feb;7(Suppl 1):S57-S59. doi: 10.21037/tlcr.2018.01.17. No abstract available.

37.

Gefitinib for advanced non-small cell lung cancer.

Sim EH, Yang IA, Wood-Baker R, Bowman RV, Fong KM.

Cochrane Database Syst Rev. 2018 Jan 16;1:CD006847. doi: 10.1002/14651858.CD006847.pub2. Review.

38.

COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.

Yang IA, Brown JL, George J, Jenkins S, McDonald CF, McDonald VM, Phillips K, Smith BJ, Zwar NA, Dabscheck E.

Med J Aust. 2017 Nov 20;207(10):436-442.

PMID:
29129177
39.

RE: Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions.

Page BJ, Bowman RV, Yang IA, Fong KM.

J Natl Cancer Inst. 2018 Apr 1;110(4):432. doi: 10.1093/jnci/djx216. No abstract available.

PMID:
29045674
40.

Ultrafine particle transport and deposition in a large scale 17-generation lung model.

Islam MS, Saha SC, Sauret E, Gemci T, Yang IA, Gu YT.

J Biomech. 2017 Nov 7;64:16-25. doi: 10.1016/j.jbiomech.2017.08.028. Epub 2017 Sep 5.

PMID:
28916396
41.

Is Digital Tomosynthesis on Par With Computed Tomography for the Detection and Measurement of Pulmonary Nodules?

Lee XW, Marshall HM, Leong SC, O'Rourke RL, Steinke K, Mirjalili N, Bowman RV, Yang IA, Fong KM.

J Thorac Imaging. 2017 Nov;32(6):W67-W68. doi: 10.1097/RTI.0000000000000298.

PMID:
28914745
42.

Low tumour cell content in a lung tumour bank: implications for molecular characterisation.

Goh F, Duhig EE, Clarke BE, McCaul E, Passmore L, Courtney D, Windsor M, Naidoo R, Franz L, Parsonson K, Yang IA, Bowman RV, Fong KM.

Pathology. 2017 Oct;49(6):611-617. doi: 10.1016/j.pathol.2017.07.001. Epub 2017 Aug 12.

PMID:
28811084
43.

Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial.

Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Marks GB, Baraket M, Powell H, Taylor SL, Leong LEX, Rogers GB, Simpson JL.

Lancet. 2017 Aug 12;390(10095):659-668. doi: 10.1016/S0140-6736(17)31281-3. Epub 2017 Jul 4.

PMID:
28687413
44.

Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology.

Taylor SL, Leong LEX, Choo JM, Wesselingh S, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Baraket M, Marks GB, Gibson PG, Simpson JL, Rogers GB.

J Allergy Clin Immunol. 2018 Jan;141(1):94-103.e15. doi: 10.1016/j.jaci.2017.03.044. Epub 2017 May 4.

45.

The effect of different radiological models on diagnostic accuracy and lung cancer screening performance.

Marshall HM, Zhao H, Bowman RV, Passmore LH, McCaul EM, Yang IA, Fong KM.

Thorax. 2017 Dec;72(12):1147-1150. doi: 10.1136/thoraxjnl-2016-209624. Epub 2017 Mar 22.

PMID:
28331076
46.

Genomics of lung cancer.

Fong KM, Bowman RV, Yang IA.

J Thorac Dis. 2017 Feb;9(2):E155-E157. doi: 10.21037/jtd.2017.02.29. No abstract available.

47.

Utility of thrombophilia testing in patients with venous thrombo-embolism.

Kudo M, Lee HL, Yang IA, Masel PJ.

J Thorac Dis. 2016 Dec;8(12):3697-3703. doi: 10.21037/jtd.2016.12.40.

48.

Periostin levels and eosinophilic inflammation in poorly-controlled asthma.

Simpson JL, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Jia G, Holweg CT, Gibson PG.

BMC Pulm Med. 2016 Apr 30;16(1):67. doi: 10.1186/s12890-016-0230-4.

49.

Acute exacerbation of COPD.

Ko FW, Chan KP, Hui DS, Goddard JR, Shaw JG, Reid DW, Yang IA.

Respirology. 2016 Oct;21(7):1152-65. doi: 10.1111/resp.12780. Epub 2016 Mar 30. Review.

50.

Screen-detected subsolid pulmonary nodules: long-term follow-up and application of the PanCan lung cancer risk prediction model.

Zhao H, Marshall HM, Yang IA, Bowman RV, Ayres J, Crossin J, Lau M, Slaughter RE, Redmond S, Passmore L, McCaul E, Courtney D, Leong SC, Windsor M, Zimmerman PV, Fong KM.

Br J Radiol. 2016;89(1060):20160016. doi: 10.1259/bjr.20160016. Epub 2016 Feb 16.

Supplemental Content

Support Center